Abstract: This invention is directed to compounds of the following formula (I): wherein R is either: wherein R1 and R2 are as defined in the specification; the use of these compounds for treating inflammatory disorders; and pharmaceutical compositions comprising a therapeutically effective amount of the above-defined compounds.
Type:
Grant
Filed:
November 6, 2006
Date of Patent:
November 13, 2007
Assignee:
Teva Pharmacaetical Industries Ltd.
Inventors:
Yaacov Herzig, David Lerner, Jeffrey Sterling